Literature DB >> 10849446

Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.

Y Kato1, M Zhao, A Morikawa, T Sugiyama, D Chakravortty, N Koide, T Yoshida, R I Tapping, Y Yang, T Yokochi, J D Lee.   

Abstract

Big mitogen-activated protein (MAP) kinase (BMK1), a member of the mammalian MAP kinase family, is activated by growth factors. The activation of BMK1 is required for growth factor-induced cell proliferation and cell cycle progression. We have previously shown that BMK1 regulates c-jun gene expression through direct phosphorylation and activation of transcription factor MEF2C. MEF2C belongs to the myocyte enhancer factor 2 (MEF2) protein family, a four-membered family of transcription factors denoted MEF2A, -2B, -2C, and -2D. Here, we demonstrate that, in addition to MEF2C, BMK1 phosphorylates and activates MEF2A and MEF2D but not MEF2B. The blocking of BMK1 signaling inhibits the epidermal growth factor-dependent activation of these three MEF2 transcription factors. The sites phosphorylated by activated BMK1 were mapped to Ser-355, Thr-312, and Thr-319 of MEF2A and Ser-179 of MEF2D both in vitro and in vivo. Site-directed mutagenesis reveals that the phosphorylation of these sites in MEF2A and MEF2D are necessary for the induction of MEF2A and 2D transactivating activity by either BMK1 or by epidermal growth factor. Taken together, these data demonstrate that, upon growth factor induction, BMK1 directly phosphorylates and activates three members of the MEF2 family of transcription factors thereby inducing MEF2-dependent gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849446     DOI: 10.1074/jbc.M001573200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Inhibition of p38 mitogen-activated protein kinase augments lipopolysaccharide-induced cell proliferation in CD14-expressing Chinese hamster ovary cells.

Authors:  D Chakravortty; Y Kato; T Sugiyama; N Koide; M M Mu; T Yoshida; T Yokochi
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

3.  14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.

Authors:  S J Choi; S Y Park; T H Han
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.

Authors:  Helen Bryant; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.

Authors:  Serge Grégoire; Xiang-Jiao Yang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish.

Authors:  Craig T Miller; Mary E Swartz; Patricia A Khuu; Macie B Walker; Johann K Eberhart; Charles B Kimmel
Journal:  Dev Biol       Date:  2007-05-24       Impact factor: 3.582

7.  MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.

Authors:  Weiyong Sun; Xudong Wei; Kamala Kesavan; Timothy P Garrington; Ruihua Fan; Junjie Mei; Steven M Anderson; Erwin W Gelfand; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Undermining the endothelium by ablation of MAPK-MEF2 signaling.

Authors:  Eric N Olson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.

Authors:  Masaaki Hayashi; Sung-Woo Kim; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; E Dale Abel; Brian Eliceiri; Young Yang; Richard J Ulevitch; Jiing-Dwan Lee
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Alternative polyadenylation in glioblastoma multiforme and changes in predicted RNA binding protein profiles.

Authors:  Jiaofang Shao; Jing Zhang; Zengming Zhang; Huawei Jiang; Xiaoyan Lou; Bingding Huang; Gregory Foltz; Qing Lan; Qiang Huang; Biaoyang Lin
Journal:  OMICS       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.